US Stock MarketDetailed Quotes

TCON Tracon Pharmaceuticals

Watchlist
  • 1.4900
  • +0.0500+3.47%
Close May 21 16:00 ET
  • 1.5600
  • +0.0700+4.70%
Post 18:32 ET
3.99MMarket Cap0.46P/E (TTM)

About Tracon Pharmaceuticals Company

TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, and ophthalmic and fibrotic diseases. Its products include TRC105, an anti-endoglin antibody for the treatment of solid tumor types, TRC205 created for the treatment of fibrotic diseases, and TRC102, a small molecule that is in clinical development made for lung cancer and glioblastoma. The company was founded in October 2004 and is headquartered in San Diego, CA.

Company Profile

SymbolTCON
Company NameTracon Pharmaceuticals
Listing DateJan 30, 2015
Issue Price10.00
Founded2004
CEODr. Charles P. Theuer, M.D.,PhD
MarketNASDAQ
Employees17
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address4350 La Jolla Village Drive,Suite 800
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92122-1243
Phone1-858-550-0780
Websitehttp://www.traconpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Charles P. Theuer, M.D.,PhD
  • Chairman of the Board, President and Chief Executive Officer
  • 1.26M
  • Scott B Brown, C.P.A.,M.S.
  • Chief Financial Officer and Principal Accounting Officer
  • 590.86K
  • David E. Lazar
  • Chief Business Development Officer
  • --
  • Carol Lam, J.D.
  • Independent Director
  • 60.33K
  • William R. Larue
  • Independent Director
  • 75.33K
  • Dr. Stephen T. Worland,PhD
  • Independent Director
  • 66.58K
  • Dr. Martin A. Mattingly,Pharm.D.
  • Independent Director
  • 69.08K
  • J. Rainer Twiford,PhD
  • Independent Director
  • 60.33K
  • Saundra Pelletier
  • Independent Director
  • 70.33K
  • Dr. Lisa R. Johnson-Pratt
  • Independent Director
  • 59.08K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg